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To date, there is a paucity of information regarding the effect of COVID-19 or lockdown on
mental disorders. We aimed to quantify the medium-term impact of lockdown on referrals
to secondary care mental health clinical services. We conducted a controlled interrupted
time series study using data from Cambridgeshire and Peterborough NHS Foundation
Trust (CPFT), UK (catchment population ∼0.86 million). The UK lockdown resulted in an
instantaneous drop in mental health referrals but then a longer-term acceleration in the
referral rate (by 1.21 referrals per day per day, 95% confidence interval [CI] 0.41–2.02).
This acceleration was primarily for urgent or emergency referrals (acceleration 0.96, CI
0.39–1.54), including referrals to liaison psychiatry (0.68, CI 0.35–1.02) and mental health
crisis teams (0.61, CI 0.20–1.02). The acceleration was significant for females (0.56,
CI 0.04–1.08), males (0.64, CI 0.05–1.22), working-age adults (0.93, CI 0.42–1.43),
people of White ethnicity (0.98, CI 0.32–1.65), those living alone (1.26, CI 0.52–2.00),
and those who had pre-existing depression (0.78, CI 0.19–1.38), severe mental illness
(0.67, CI 0.19–1.15), hypertension/cardiovascular/cerebrovascular disease (0.56, CI
0.24–0.89), personality disorders (0.32, CI 0.12–0.51), asthma/chronic obstructive
pulmonary disease (0.28, CI 0.08–0.49), dyslipidemia (0.26, CI 0.04–0.47), anxiety
(0.21, CI 0.08–0.34), substance misuse (0.21, CI 0.08–0.34), or reactions to severe
stress (0.17, CI 0.01–0.32). No significant post-lockdown acceleration was observed
for children/adolescents, older adults, people of ethnic minorities, married/cohabiting
people, and those who had previous/pre-existing dementia, diabetes, cancer, eating
disorder, a history of self-harm, or intellectual disability. This evidence may help service
planning and policy-making, including preparation for any future lockdown in response
to outbreaks.
Keywords: COVID-19/SARS-CoV-2 coronavirus pandemic, lockdown, secondary care mental health services,
controlled interrupted time series analysis, comorbidity
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INTRODUCTION
The 2019 novel coronavirus disease (COVID-19) was declared
a pandemic by the World Health Organization (WHO) on 11
March 2020 (1). To minimize transmission, “social distancing”
or “lockdown” measures were adopted as public health measures
globally, including in the United Kingdom (UK), which
commenced social distancing from 16 May 2020 and lockdown
rules from 23 March 2020.
It is already evident that COVID-19 and lockdown have
the potential to lead to pervasive mental health problems. Li
et al. (2) surveyed 5,033 individuals from the general population
in China following the local onset of COVID-19 and found
that 20.4% of people had anxiety or depression or both. Ni
et al. (3) surveyed 1,577 adults in China and found that 23.8
and 19.2% of people reported probable anxiety and depression,
respectively. Moghanibashi-Mansourieh (4) surveyed 10,754
individuals from the general population in Iran and found
that 19.1% of people had severe symptoms of anxiety. A
survey in the UK (5) involving 2,198 members of the general
population also revealed widespread concerns about COVID-
19 and mental health problems. A recent position paper (6)
noted that besides the rise in adverse mental symptoms, there
is also a risk of increasing numbers of people suffering clinically
significant mental disorders. However, the effects of the COVID-
19 pandemic and state-imposed lockdown on public mental
health in a clinical setting have not been evaluated systematically,
and current evidence is mainly based on online surveys. In
addition, the evidence relating to long-term consequences of the
COVID-19 lockdown upon mental health is sparse (6). Such
evidence is urgently needed to inform interventions and for
policy makers to formulate an appropriate response.
It has been suggested (7–12) that vulnerable groups such as
children and adolescents, pregnant women, older adults, and
people with pre-disposing physical and mental health conditions
could suffer disproportionately from mental health problems
resulting from the current COVID-19 lockdown. Relevant
evidence is similarly sparse, and similarly required.
The present study investigated the impact of lockdown on
referrals to secondary care mental health clinical services. In
addition to examining the overall impact, we also performed
a series of sub-group analyses paying special attention to
vulnerable groups. As well as the short-term (instantaneous)
effect of lockdown, we focused on the subsequent rate of change
over time (the longer-term, or medium-term, effect).
METHODS
Study Design and Participants
We conducted a controlled interrupted time series (CITS)
study (13), testing the hypothesis of a causal effect of
COVID-19 lockdown, using a historical control group (14).
Data were derived from the electronic clinical records of
Cambridgeshire and Peterborough NHS Foundation Trust
(CPFT), UK. CPFT provides physical and mental health services
to a population of approximately 0.86 million. Its records
contains patient information recorded during routine treatment,
such as age, gender, ethnicity, marital status, referral time, referral
destination, diagnoses, and (in free text) some prescription data.
De-identified data were extracted via the CPFT Research
Database (NHS Research Ethics 17/EE/0442). We included all
records from 2020-01-01 to 2020-03-15 as the pre-lockdown
period in 2020, and records from 2020-03-23 to 2020-05-19 as
the post-lockdown period. Records from 16 March to 22 March
were excluded because this was a transition period (from social
distancing to lockdown). Records from 2019-01-01 to 2019-03-
15, and from 2019-03-23 to 2019-05-19, were included as the
corresponding control year. Weekends were excluded, and bank
holidays were excluded from day-by-day analyses.
Variables
We examined daily referral numbers to mental health service
teams. Subgroup CITSs were also conducted, by gender, age,
ethnicity, marital status, referral urgency, referral destination
(service referred to), and pre-existing diseases. Age was divided
into three ranges: 0–19 years (children and adolescents), 20–
64 years (working-age adults), and ≥65 years. Ethnicity was
categorized into three groups: White, ethnic minorities, and
unknown. Marital status was categorized into two groups:
cohabiting/married, and single/divorced/widowed. Level of
urgency was recorded by clinicians and was grouped into two
levels: routine, and urgent/emergency. Referral destination was
grouped into 13 team/service categories: crisis teams, liaison
psychiatry, personality disorder services, perinatal mental health,
autistic spectrum disorder services, eating disorder services,
learning disability teams, substance misuse teams, memory
or dementia services, psychological therapy services, forensic
services, community mental health teams, and others.
Pre-existing diseases were judged based on WHO
International Classification of Diseases (ICD-10) codes and
on prescription information. Clinician-recorded diagnoses were
present in coded data. Medicine information was extracted from
free text using GATE-based natural language processing (NLP)
software (15). The diseases we focused on included dementia
(recorded with ICD-10 codes F00-F03 and G30, or indicated
by mentions of cholinesterase inhibitors or glutamate receptor
antagonists), substance misuse (F10-F19), severe (serious)
mental illness (F20-F29, F30, and F31, or taking antipsychotics),
depression (F32 or F33, or taking antidepressants), anxiety
(F41 or F42), reaction to severe stress/adjustment disorders
(F43), eating disorders (F50), personality disorders (F60-F69),
intellectual disability (F70-F79), intentional self-harm (X60-
X84), diabetes mellitus (E10-E14, or taking hypoglycemic
agents), hypertension or cardiovascular or cerebrovascular
disease (I10-I13, I15, I21-I25, and I60-I69, or taking ACE
inhibitors, angiotensin-II receptor antagonists, beta blockers,
calcium channel antagonists, or diuretics), dyslipidemia (E78,
or taking lipid-lowering medications), asthma or chronic
obstructive pulmonary disease (COPD) (J44, J45, or taking
oral or inhaled corticosteroids, bronchodilators, or anti-
inflammatory drugs used for airways disease, accepting that
oral corticosteroids may also indicate other inflammatory
disorders), and cancer (C00-C97, or taking drugs specifically
licensed for cancer). Identification of these diseases were based
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on CPFT records up to 1 year before a referral was made,
except for lifelong diseases including dementia, severe mental
illness and the aforementioned physical diseases (for which a
record at any time was included). The medicines referred to
were selected according to UK National Institute for Health
and Care Excellence (NICE) guidelines and are listed in
Supplementary Table 1.
Statistical Analysis
We report referral frequency as mean with standard deviation.
For the CITS, data were fitted using the following equation:
y = β0 + β1 · Time + β2 · Phase + β3 · Phase · Time
+ β4 · Year + β5 · Year · Time + β6 · Year · Phase
+ β7 · Year · Phase · Time + Month + Weekday + error
(1)
where y is the daily number of referrals; Time is the time point of
data (within a phase); Phase indicates “before/after lockdown or
equivalent period” (0 before lockdown in 2020 or the equivalent
period in 2019, and 1 after lockdown in 2020 or the equivalent
period in 2019); Phase×Timewas the time after lockdown in 2020
or the equivalent point in 2019; Year indicates 2020 (0 for control
data from 2019, or 1 for 2020); Year×Time was time for 2020
and 0 for 2019; Year×Phase was 1 after lockdown, or 0 before
lockdown and during the control year; Year×Phase×Time was
the time after lockdown, or 0 before lockdown and during the
control year.
The coefficients in equation 1 are described elsewhere (16)
and in Table 2. Two are of particular importance with respect
to lockdown. β6 reflects the short-term change (instantaneous
effect) resulting from lockdown, over and above any equivalent
change that may have occurred in 2019. β7 was the coefficient
of primary interest in this study, and represents the longer-
term effect of lockdown, namely the slope change in referral rate
following lockdown (after any instantaneous effect and relative to
the pre-lockdown slope), over and above any equivalent change
in the control year (2019).
Equation 1 was fitted by negative binomial regression, in view
of overdispersion seen in the referral numbers. To control for
seasonal trends, the day of week and month were also included
in the regression. The Breusch–Godfrey and Breusch–Pagan tests
were used to check for autocorrelation and heteroskedasticity
of residuals, respectively. To interpret the fitted result, a linear
approximation to the negative binomial was performed by
estimating the marginal effects (ME) and 95% confidence
intervals (CI) for the means.
Sensitivity analyses were conducted by examining weekly
instead of daily referral numbers.
All statistical analysis were performed using R (version 3.5.0).
Statistical significance was defined as P < 0.05, and all tests were
two-tailed. Missing data were not imputed.
Patient and Public Involvement
Service user and carer representatives assessed this programme
of work and approved it as members of the CPFT Research
Database Oversight Committee, but were not involved in the
development of this research question or the outcome measures,
or in developing plans for the design and implementation of
the study.
RESULTS
Table 1 shows the number of referrals before and after lockdown
in 2020, and during the equivalent control periods. After
lockdown, there was an immediate decrease in the number of
referrals to mental health services. A decrease was also seen in
the control period, but the decrease was much larger in 2020
than in 2019. Similar results were observed for subgroups. As
shown in Figure 1, there was no difference in the trend between
the pre-lockdown period in 2020 and the equivalent period in
2019. However, after lockdown, there was a substantial drop in
the referral rate and then an acceleration of referrals compared to
the control period.
Table 2 shows the overall regression results. After controlling
for seasonal trends, neither the mean referral rate (β4, 6.06,
95% CI −6.41 to 18.53) nor the time trend in referral rate (β5,
−0.21, CI −0.58 to 0.16) was significantly different between the
pre-lockdown period in 2020 and its control period in 2019.
This indicated that 2019 could be treated as a homogenous
counterpart to 2020, before lockdown. Controlling for other
temporal effects, lockdown resulted in an immediate decrease
in the total number of referrals, by 72 referrals·day−1 (short-
term effect, β6, CI −85.13 to −58.14), and a subsequent
acceleration in referrals, of 1.21 referrals·day−2 (medium-
term effect, β7, CI 0.41 to 2.02). There was no significant
autocorrelation or heteroskedasticity in the fitted residuals (see
Supplementary Table 2, Supplementary Figure 1).
Subgroup analyses are shown in Figure 2 (short-term
effect) and Figure 3 (longer-term effect). The immediate
decrease in referral rate to mental health services (β6) remained
statistically significant for both genders; all age groups; those
of White ethnicity; both levels of marital status; both levels
of urgency; referrals to community mental health teams,
liaison psychiatry, crisis teams, autistic spectrum disorder
teams, memory/dementia services, and personality disorder
services; and for those who had pre-existing depression,
hypertension/cardiovascular/cerebrovascular disease, and
reaction to severe stress. After these immediate effects of
lockdown, there was an acceleration (β7) in urgent/emergency
referrals (0.96 referrals·day−2, CI 0.39 to 1.54), and in referrals
to liaison psychiatry (0.68, CI 0.35 to 1.02) and mental
health crisis teams (0.61, CI 0.20 to 1.02). The acceleration
remained significant for both genders (females 0.56, CI 0.04
to 1.08, males 0.64, CI 0.05 to 1.22); working-age adults
(0.92, CI 0.42 to 1.43); those of White ethnicity (0.98, CI
0.32 to 1.65), those living alone (1.26, CI 0.52 to 2.00); and
those who had previous or pre-existing depression (0.78, CI
0.19 to 1.34), severe mental illness (0.67, CI 0.19 to 1.15),
hypertension/cardiovascular/cerebrovascular disease (0.56, CI
0.24 to 0.89), personality disorders (0.32, CI 0.12 to 0.51),
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TABLE 1 | Referrals per day to secondary care mental health services, shown as mean (SD).
Year 2020 Year 2019
Before lockdown (a) After lockdown (b) Change,
b – a
Control data for (a) Control data for (b) Change,
control (b) –
control (a)
Overall 196.48 (15.98) 132.79 (18.87) −63.69 196 (20.5) 190.55 (14.52) −5.45
Gender
Female 109.19 (11.7) 73.44 (10.54) −35.75 108.55 (15.04) 105.47 (10.89) −3.08
Male 86.62 (8.5) 59.31 (12.16) −27.31 87.28 (11.8) 84.97 (10.7) −2.31
Age
0–19 35.23 (8.27) 19 (6.03) −16.23 32.19 (8.88) 33.39 (8.43) 1.2
20–64 118.31 (12.62) 89.79 (12.42) −28.52 120.47 (13.44) 114.11 (11.84) −6.36
≥65 42.94 (7.85) 24 (7.38) −18.94 43.32 (8.59) 43.03 (6.38) −0.29
Ethnicity
White 150.73 (15.02) 103.03 (15.01) −47.7 157.26 (17.67) 152.92 (11.84) −4.34
Ethnic minorities 12.79 (4.13) 10.26 (3.68) −2.53 14.74 (3.93) 13.26 (4.94) −1.48
Unknown 32.96 (5.83) 19.51 (5.53) −13.45 24 (5.76) 24.37 (4.9) 0.37
Marital status
Single/divorced/widowed 166.44 (14.19) 112.03 (17.75) −54.41 160.19 (17.66) 156.89 (13.78) −3.3
Cohabiting/married 30.04 (5.34) 20.77 (5.04) −9.27 35.81 (7.4) 33.66 (5.26) −2.15
Level of urgency
Routine 110.5 (14.21) 64.1 (12.59) −46.4 111.09 (16.49) 106.13 (13.52) −4.96
Urgent/emergency 85.98 (11.51) 68.69 (14.67) −17.29 84.91 (12.51) 84.42 (11.72) −0.49
Referral destination
Crisis teams 77.62 (8.49) 69.95 (10) −7.67 78.64 (9.34) 73.82 (8.77) −4.82
Community mental health
teams
48.12 (9.21) 22.49 (6.2) −25.63 44.28 (9.78) 46.13 (8.54) 1.85
Liaison psychiatry 40.21 (7.36) 24.08 (6.87) −16.13 36.36 (6.93) 35.71 (6.13) −0.65
Memory/dementia services
teams
3.85 (1.95) 2.62 (1.63) −1.23 7.23 (2.8) 7.45 (3.8) 0.22
Forensic service teams 2.94 (2.02) 2.6 (1.65) −0.34 6.73 (6.85) 2.92 (1.56) −3.81
Autistic spectrum disorder
teams
4.63 (2) 1.73 (1.08) −2.9 6.41 (3.35) 6.86 (3.36) 0.45
Eating disorders teams 4.77 (2.24) 3.22 (1.93) −1.55 4.25 (2.08) 3.81 (1.87) −0.44
Personality disorder teams 2.85 (2.68) 2.52 (1.91) −0.33 2.59 (1.57) 3.06 (1.61) 0.47
Learning disability teams 1.98 (0.88) 2 (0.95) 0.02 2.27 (1.36) 2.21 (1.24) −0.06
Psychological therapy
services teams
4.02 (2.2) 2.61 (2.25) −1.41 1.69 (0.81) 2.22 (1.39) 0.53
Perinatal mental health teams 3.78 (2.06) 3.03 (2.09) −0.75 3.54 (1.95) 3.78 (1.92) 0.24
Substance misuse teams 5.5 (1.43) 1.88 (1.46) −3.62 3.8 (2.25) 2.89 (1.45) −0.91
Other 2.71 (1.86) 1.15 (0.38) −1.56 3.96 (2.08) 3.59 (1.59) −0.37
Pre-existing condition
Dementia 12.79 (4.39) 7.85 (3.45) −4.94 16.74 (5.5) 11.45 (3.42) −5.29
Substance misuse 5.9 (2.87) 4.61 (2.15) −1.29 6.49 (3.32) 5.54 (3.17) −0.95
Serious mental illness 71.31 (9.08) 58.95 (10.75) −12.36 72.32 (9.98) 64.61 (8.82) −7.71
Depression 102.04 (11.2) 75.82 (13.06) −26.22 98.91 (12.51) 90.87 (11.89) −8.04
Anxiety 7.31 (3.33) 5.72 (2.92) −1.59 6.98 (2.49) 5.16 (2.72) −1.82
Eating disorders 3.06 (2.02) 1.87 (0.96) −1.19 2.92 (1.63) 2.32 (1.39) −0.6
Reaction to severe stress 10.08 (3.24) 6.97 (3.45) −3.11 8.02 (3.12) 7.21 (3.73) −0.81
Personality disorders 15.25 (3.68) 11.69 (3.85) −3.56 16.75 (4.95) 13.26 (4.32) −3.49
Intellectual disability 1.33 (0.65) 1.6 (0.89) 0.27 1 (0) 1.75 (0.96) 0.75
Diabetes mellitus 11.96 (4.75) 9.49 (2.76) −2.47 12.53 (3.89) 12.29 (3.81) −0.24
Hypertension, cardiovascular,
and cerebrovascular disease
40.42 (7.3) 30.79 (6.01) −9.63 53.92 (8.94) 48.45 (6.93) −5.47
Cancer 1.3 (0.56) 1.8 (1.01) 0.5 1.39 (0.67) 1.2 (0.41) −0.19
Dyslipidemia 19.5 (4.36) 16.03 (3.77) −3.47 28.98 (5.74) 26.26 (5.51) −2.72
Asthma/COPD 17.08 (4.55) 12.21 (4.2) −4.87 21.7 (4.88) 18.76 (4.95) −2.94
Intentional self-harm 5.76 (2.52) 5.26 (2.33) −0.5 5.73 (2.49) 5.08 (2.8) −0.65
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FIGURE 1 | Interrupted time series analysis of referrals to secondary care mental health services in 2020 (red) and 2019 (blue). The dashed line is the model fit. The
gray area indicates the transition period from social distancing (16 March 2020) to lockdown (23 March 2020).
TABLE 2 | Overall controlled interrupted time-series analysis: negative binomial regression adjusted for seasonal effects (month and day of week). The dependent variable
is the referral rate (referrals·day−1).
Variable Coefficient Explanation Units Marginal effect (95% CI) P
Time β1 Trend in 2019 before 16 March Referrals·day
−2 0.29 (−0.19, 0.77) 0.2365
Phase β2 Step change in the referral rate in 2019, from before
16 March to after 22 March
Referrals·day−1 −10.54 (−20.87, −0.21) 0.0455
Phase × Time β3 Trend change (rate of change of referral rate) in
2019 after 22 March
referrals·day−2 −0.18 (−0.58, 0.21) 0.3609
Year β4 The difference in the referral rate between the
pre-lockdown period in 2020 and the equivalent
control period in 2019
Referrals·day−1 6.06 (−6.41, 18.53) 0.3411
Year × Time β5 The difference in the rate of change (in referral rate)
over time between the pre-lockdown period in 2020
and the equivalent control period in 2019
Referrals·day−2 −0.21 (−0.58, 0.16) 0.2737
Year × Phase β6 Short-term (instantaneous) effect of lockdown. The
difference between the referral rate during the
post-lockdown period in 2020 and that during the
equivalent control period in 2019, each relative to
the referral rate during the pre-lockdown period
Referrals·day−1 −71.64 (−85.13, −58.14) <0.0001
Year × Phase × Time β7 Longer-term (medium-term) effect of lockdown.
Rate of change (in referral rate) after lockdown, over
and above any corresponding change during the
equivalent control period
Referrals·day−2 1.21 (0.41, 2.02) 0.0032
Bold text indicates p < 0.05.
asthma/COPD (0.28, CI 0.08 to 0.49), dyslipidemia (0.26,
CI 0.04 to 0.47), anxiety (0.21, CI 0.08 to 0.34), substance
misuse (0.20, CI 0.06 to 0.34), or reactions to severe stress
(0.17, CI 0.01 to 0.32). No significant longer-term rate
changes were observed for children and adolescents, older
adults, people of ethnic minorities, married/cohabiting
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FIGURE 2 | Short-term (β6) effects of COVID-19 lockdown on the daily number of referrals to mental health services for subgroups. Units are referrals·day
−1.
people, or those who had pre-existing dementia, diabetes,
cancer, eating disorder, a history of intentional self-harm, or
intellectual disability.
Sensitivity analyses confirmed this pattern of results
(Supplementary Figures 2, 3).
DISCUSSION
To our knowledge, this is the first study to evaluate systematically
the longer-term effects of COVID-19 lockdown on a population’s
mental health in a clinical setting via a detailed examination of
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FIGURE 3 | Medium-term (β7) effects of COVID-19 lockdown on the time trend in referrals to mental health services for subgroups. Units are referrals·day
−2.
the trajectory of referral numbers. With a rigorous study design
to detect causal effects in time series data, we found that after
an initial decrease (17), lockdown led in the medium term to
an acceleration in the rate of referrals. The significant longer-
term effects revealed in our study are generally consistent with
the mental health concerns associated with COVID-19 raised by
others. However, the finding was to some extent inconsistent
with a study conducted by Wang et al. (18). They conducted
two online cross-sectional studies in China, 4 weeks apart, and
found no significant changes in scores of depression, anxiety,
and stress. This might be partially attributed to the variations in
methodology and characteristics of study participants (e.g., the
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online design, the relatively small sample size of Wang’s study,
and the measurement of self-reported mental health problems).
Given that our study was conducted in a clinical setting, had
a longer duration, and used a more rigorous design for causal
inference, we suggest our findings are more representative
of clinical practice compared with previous cross-sectional or
online surveys that used screening scales for mental disorders.
The significant medium-term effects of COVID-19 lockdown
on referrals to mental health services were observed in multiple
subgroups, supporting the validity of the findings. For instance,
after lockdown, referrals accelerated again across genders.
Unexpectedly, no such acceleration was observed among those
aged ≤19 or ≥65, who have been suspected to be especially
vulnerable to mental health problems resulting from social
distancing or lockdown (10, 12, 19–21), even though all age
groups exhibited the significant instantaneous drop in referrals
at lockdown. The lack of acceleration in referrals for older adults
after lockdown was also to some extent inconsistent with a study
(22) conducted in Hong Kong at the time of the severe acute
respiratory syndrome (SARS) epidemic in 2003, which found
SARS to be associated with a 30% increase in suicide in those aged
≥65. A possible reason why referrals did not accelerate again for
this group may have been that some older people who lived alone
and without close support may have lost their capability to access
services as usual (19). Fear of contracting COVID-19 infection in
a healthcare setting might also have deterred people from seeking
help for their mental health, especially for the elderly (for whom a
UK public campaign emphasized their additional vulnerability).
Similarly, we did not observe a significant post-lockdown
acceleration in referrals for those from ethnic minorities,
though this acceleration was significant for those of White
ethnicity (indeed, the acceleration for the ethnic minority
group was significantly less). Although the immediate lockdown-
associated change in referrals for those of ethnic minorities
was also not significant, this observation, coupled with the
fact that ethnic minority groups are already at elevated
risk of dying from COVID-19 in the UK (23), raises the
concern that they may not be obtaining mental health support
proportionally following lockdown. Together with the lack of
acceleration observed in children/adolescents and elderly people,
these findings should prompt consideration as to whether
these represent disadvantaged groups requiring active mental
health intervention.
A significant contribution of this study is that we explored the
post-lockdown trends in referral by service referred to, which
indirectly suggests the type and degree of mental disorders to
which the lockdown may lead. The post-lockdown acceleration
in referrals to liaison psychiatry and crisis teams is in keeping
with the fact that the acceleration was for urgent/emergency
rather than routine referrals (which may also reflect a reduction
in routine services). It has been hypothesized (6) and suggested
by two cross-sectional studies that COVID-19 might lead to an
increase in depressive symptoms and anxiety amongst pregnant
women (24, 25). In contrast, our study found neither an initial
change nor a subsequent rate of change in the referral rate
to perinatal mental health teams. This may reflect service
supply as well as patient demand factors, but this inconsistency
clearly shows that the increase of mental symptoms assessed by
screening scales may not necessarily predict clinical referrals for
mental disorders.
This study also provides evidence about the longer-term effect
of lockdown on referrals for patients with pre-existing diseases,
suggesting indirectly which groups of patients suffermoremental
ill health during the lockdown, and providing implications
for resource planning and clinical management. Our results
give support to concerns that those with severe mental illness
(11, 26, 27) would be particularly vulnerable to the long-term
effects of lockdown. Our results also indicate that patients with
previous/pre-existing depression, personality disorders, anxiety,
substance misuse, and reactions to severe stress also required
accelerating rates of referral after lockdown, and may need
early intervention to prevent the relapse or aggravation of pre-
existing mental disorders or the emergence of new problems.
Previous cross-sectional studies (28–31) indicated that people
with poorer self-reported health status, or comorbid chronic
diseases, were more likely to report mental health problems. Our
study found that patients who had hypertension, cardiovascular,
cerebrovascular disease, asthma, COPD, or dyslipidemia showed
accelerating rates of mental health referrals after COVID-19
lockdown. [Hypertension and dyslipidemia are perhaps notable
as largely asymptomatic disorders; the association here may
reflect an indirect relationship via other conditions, be they
physical, such as other cardiometabolic diseases, or psychiatric,
such as depression (32).] Special attention may need to be paid
to the mental health of patients with chronic cardiovascular or
respiratory diseases.
Notably, referral types that showed the greatest initial drop
(Figure 2) tended to show the largest subsequent rate increase
(Figure 3). Referral numbers reflect the actions of professionals,
and the instantaneous drop reflected, in part, attempts by health
services tominimize the probability of patients entering high-risk
areas for infection unnecessarily (17), and to release resources
for the management of patients with COVID-19. However,
it is less clear that this explains the subsequent increase in
referral rates. Therefore, although it is possible that the longer-
term effects identified in this study may not result solely from
the social consequences of COVID-19 lockdown but also from
adaptation and “rebound” of the health system from the initial
sharp decline resulting from lockdown, the prior probability
that the changes observed were caused by the pandemic is
extremely high and this may have been direct or via a range
of indirect mechanisms. For example, these effects may reflect
both changes in supply (reduced provision of health services,
and the prioritization of urgent over routine referrals with
discouragement of routine referral) as well as changes in patient-
led demand (17). Regression to the mean (“what went down
most, came up most”) cannot explain our data fully. Routine
referrals, for example, decreased substantially but then did not
increase accordingly. This may have reflected service-driven
pressures to reduce non-urgent activity. Referrals for people who
were married/cohabiting dropped at lockdown, but then did not
increase subsequently, perhaps reflecting less mental health need
in this group compared with people who live alone. Referrals
for people with pre-existing asthma/COPD did not decrease
significantly at lockdown but still increased subsequently. This
is in keeping with the suggestion that COVID-19 imposes
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particular additional mental stress on patients with pre-existing
respiratory disease (33, 34).
Our findings are, of course, correlational and do not
prove causality. However, a number of potential mitigating
strategies may be applicable to “lockdown.” First, mental
health services must to be able to deliver services to all in
need, by operating a flexible mix of in-person and remote
(e.g., videoconferencing) consultations to balance clinical and
infection control requirements; there is not a “one size fits all”
approach (35). Secondly, referrers should be encouraged to have
a low threshold for potentially vulnerable populations (including
children, the elderly, those of ethnic minorities, those who are
socially isolated, and those with pre-existing mental disorders
and physical comorbidities). Thirdly, evidence-based measures
to support population mental health (36)—including the
promotion of community cohesion (37)—are likely to be helpful,
and to require government support (36). Such interventions
may be constrained additionally by the economic effects of the
pandemic, and governments must balance economic and health
considerations. However, it is notable that personal economic
loss during lockdown is associated with worsening of mental
health, particularly an increase in depressive symptoms (38), and
that explicit consideration of the trade-offs between infective
and economic/wellbeing considerations may be required for
maximum public benefit (39).
Our study had several limitations. First, we used clinical data
up to ∼2 months after UK lockdown; this may not be long
enough for some effects of lockdown to have become evident.
Second, the referral data used in this study could only reflect
problems severe enough to require referral to secondary care
mental health services. Thus, this study may underestimate
longer-term effects, as some individuals may have been suffering
mental health problems resulting from COVID-19/lockdown
but used primary care services only, or did not seek mental
health services at all. The present findings thus highlight mental
health needs and a disease burden that should be prioritized for
attention and treatment. Third, classifying by diagnosis instead
of referral service would be more helpful to establish disease
patterns, but frequent missing coded data on diagnosis following
urgent or emergency referrals impeded our analysis. Fourth,
some types of referral, for example for people with diabetes or
cancer, were relatively rare in the dataset, posing a challenge (via
low power) to identifying the effects of lockdown upon them.
We addressed this by performing sensitivity analyses examining
weekly instead of daily referral numbers; this confirmatory
analysis supported our primary results. Finally, our findings may
not generalize to other areas, such as with very different COVID-
19 infection rates, or health service organization. However,
measures such as social distancing and lockdown are being
adopted in similar ways internationally, so the results of the
present study may be useful for other regions and countries.
CONCLUSIONS
The present study, using clinical records and the optimal causal
inference study design for time series analysis, is compatible
with the hypothesized negative long-term impact of lockdown
on mental health. After an initial drop in referrals, we observed
a post-lockdown acceleration in urgent and emergency mental
health referrals. This acceleration was significant for adults
of working age, people who live alone, and those with a
broad range of pre-existing mental disorders and a subset
of physical comorbidities. No such acceleration was observed
for children/adolescents, older adults, and those from ethnic
minorities; one possibility is that they may be facing insufficient
access to mental health services. The timely evidence in this study
could help the response of mental health systems and policy to
support population mental health, as well as in preparation for
any future lockdown in response to further outbreaks.
DATA AVAILABILITY STATEMENT
The data analyzed in this study is subject to the following
licenses/restrictions: Patient-level data is not publicly available,
under NHS Research Ethics terms. Source code and summary
data are available on request. Requests to access these datasets
should be directed to Rudolf N. Cardinal, rnc1001@cam.ac.uk.
ETHICS STATEMENT
The studies involving human participants were reviewed and
approved by the NHS Health Research Authority Cambridge
Central Research Ethics Committee (reference 17/EE/0442)
and CPFT Research Database Oversight Committee. Written
informed consent from the participants’ legal guardian/next of
kin was not required to participate in this study in accordance
with national legislation and institutional requirements.
AUTHOR CONTRIBUTIONS
SC and RC contributed to the study design and wrote the first
draft. SC and JL processed the data. SC conducted the statistical
analyses. All authors edited and approved the final manuscript.
FUNDING
SC’s, JN’s, and RC’s research was supported by the Medical
Research Council (grant MC_PC_17213 to RC). This research
was supported in part by the UK National Institute for Health
Research (NIHR) Cambridge Biomedical Research Centre.
ACKNOWLEDGMENTS
We thank Phil Alsop, Chris Carling, Golam Khandaker, Linda
Jones, Rachel Kyd, Iliana Rokkou, Ginny Russell, and Mary-Beth
Sherwood for providing oversight. We thank our referees for
helpful comments.
SUPPLEMENTARY MATERIAL
The Supplementary Material for this article can be found
online at: https://www.frontiersin.org/articles/10.3389/fpsyt.
2020.585915/full#supplementary-material
Frontiers in Psychiatry | www.frontiersin.org 9 November 2020 | Volume 11 | Article 585915
Chen et al. COVID-19 Mental Health Referral Trajectories
REFERENCES
1. World Health Organization. Timeline of WHO’s Response to COVID-19.
(2020). Available online at: https://www.who.int/news-room/detail/29-06-
2020-covidtimeline (accessed July 7, 2020).
2. Li J, Yang Z, Qiu H, Wang Y, Jian L, Ji J, et al. Anxiety and
depression among general population in China at the peak of the
COVID-19 epidemic. World Psychiatry. (2020) 19:249–50. doi: 10.1002/wp
s.20758
3. Ni MY, Yang L, Leung CMC, Li N, Yao XI, Wang Y, et al. Mental
health, risk factors, and social media use during the COVID-19 epidemic
and cordon sanitaire among the community and health professionals
in Wuhan, China: cross-sectional survey. JMIR Ment Health. (2020)
7:e19009. doi: 10.2196/19009
4. Moghanibashi-Mansourieh A. Assessing the anxiety level of Iranian
general population during COVID-19 outbreak. Asian J Psychiatr. (2020)
51:102076. doi: 10.1016/j.ajp.2020.102076
5. Academy of Medical Royal Colleges, MQ. Survey Results: Understanding
People’s Concerns About the Mental Health Impacts of the COVID-19
Pandemic. (2020). Available online at: https://acmedsci.ac.uk/file-download/
99436893 (accessed May 22, 2020).
6. Holmes EA, O’Connor RC, Perry VH, Tracey I, Wessely S, Arseneault L,
et al. Multidisciplinary research priorities for the COVID-19 pandemic: a
call for action for mental health science. Lancet Psychiatry. (2020) 7:547–
60. doi: 10.1016/S2215-0366(20)30168-1
7. Zeng L-N, Chen L-G, Yang C-M, Zeng L-P, Zhang L-Y, Peng T-M.
Mental health care for pregnant women in the COVID-19 outbreak
is urgently needed. Women Birth. (2020) doi: 10.1016/j.wombi.2020.
03.009
8. Pfefferbaum B, North CS. Mental health and the Covid-19 pandemic. N Engl
J Med. (2020) 383:510–12. doi: 10.1056/NEJMp2008017
9. Yang Y, LiW, Zhang Q, Zhang L, Cheung T, Xiang Y-T. Mental health services
for older adults in China during the COVID-19 outbreak. Lancet Psychiatry.
(2020) 7:e19. doi: 10.1016/S2215-0366(20)30079-1
10. Lee J. Mental health effects of school closures during COVID-19.
Lancet Child Adolesc Health. (2020) 4:421. doi: 10.1016/S2352-4642(20)3
0109-7
11. Druss BG. Addressing the COVID-19 pandemic in populations
with serious mental illness. JAMA Psychiatry. (2020) 77:891–
2. doi: 10.1001/jamapsychiatry.2020.0894
12. Golberstein E, Wen H, Miller BF. Coronavirus disease 2019.
(COVID-19) and mental health for children and adolescents.
JAMA Pediatr. (2020) 174:819–20. doi: 10.1001/jamapediatrics.202
0.1456
13. Hawton K, Bergen H, Simkin S, Dodd S, Pocock P, Bernal W,
et al. Long term effect of reduced pack sizes of paracetamol on
poisoning deaths and liver transplant activity in England and Wales:
interrupted time series analyses. BMJ. (2013) 346:f403. doi: 10.1136/bm
j.f403
14. Lopez Bernal JA, Lu CY, Gasparrini A, Cummins S, Wharam JF, Soumerai
SB. Association between the 2012 Health and Social Care Act and
specialist visits and hospitalisations in England: a controlled interrupted time
series analysis. PLoS Med. (2017) 14:e1002427. doi: 10.1371/journal.pmed.1
002427
15. Cardinal RN. Clinical records anonymisation and text extraction. (CRATE):
an open-source software system. BMC Med Inform Decis Mak. (2017)
17:50. doi: 10.1186/s12911-017-0437-1
16. Bernal JL, Cummins S, Gasparrini A. Interrupted time series regression for
the evaluation of public health interventions: a tutorial. Int J Epidemiol. (2017)
46:348–55. doi: 10.1093/ije/dyw098
17. Chen S, Jones PB, Underwood BR, Moore A, Bullmore ET, Banerjee
S, et al. The early impact of COVID-19 on mental health and
community physical health services and their patients’ mortality
in Cambridgeshire and Peterborough, UK. J Psychiatr Res. (2020)
131:244–54. doi: 10.1016/j.jpsychires.2020.09.020
18. Wang C, Pan R, Wan X, Tan Y, Xu L, McIntyre RS, et al. A longitudinal study
on the mental health of general population during the COVID-19 epidemic
in China. Brain Behav Immun. (2020) 87:40–48. doi: 10.1016/j.bbi.2020.
04.028
19. Wang H, Li T, Gauthier S, Yu E, Tang Y, Barbarino P, et al. Coronavirus
epidemic and geriatric mental healthcare in China: how a coordinated
response by professional organizations helped older adults during
an unprecedented crisis. Int Psychogeriatr. (2020) 32:1117–1120.
doi: 10.1017/S1041610220000551
20. Webb L. COVID-19 lockdown: a perfect storm for older people’s
mental health. J Psychiatr Ment Health Nurs. (2020) doi: 10.1111/j
pm.12644
21. Banerjee D. The impact of Covid-19 pandemic on elderly mental health. Int J
Geriatr Psychiatry. (2020) doi: 10.1002/gps.5320
22. Yip PSF, Cheung YT, Chau PH, Law YW. The impact of epidemic
outbreak: the case of severe acute respiratory syndrome. (SARS)
and suicide among older adults in Hong Kong. Crisis. (2010)
31:86–92. doi: 10.1027/0227-5910/a000015
23. Office for National Statistics. Coronavirus. (COVID-19) Related
Deaths by Ethnic Group, England and Wales: 2 March 2020 to
15 May 2020. (2020). Available online at: https://www.ons.gov.uk/
peoplepopulationandcommunity/birthsdeathsandmarriages/deaths/
articles/coronaviruscovid19relateddeathsbyethnicgroupenglandandwales/
2march2020to15may2020 (accessed June 19, 2020).
24. Wu Y, Zhang C, Liu H, Duan C, Li C, Fan J, et al. Perinatal
depressive and anxiety symptoms of pregnant women during the coronavirus
disease 2019 outbreak in China. Am J Obstet Gynecol. (2020) 223:240.e1-
9. doi: 10.1016/j.ajog.2020.05.009
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